Tung, N. M., Zhao, F., Partridge, S. C., Wright, J., Recht, A., Weiss, A., Tjoe, J. A., Feldman, S. M., Rocque, G. B., Smith, M. L., O'Sullivan, C. C., Sardesai, S. D., Badve, S. S., Winer, E. P., Miller, K. D., Partridge, A. H., Carey, L. A., Rahbar, H., DeMichele, A., Wolff, A. C. (2026). EA1181: Accuracy of pre-surgery MRI to predict pathologic complete response after taxane, trastuzumab, and pertuzumab (THP) in HER2-positive breast cancer.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.603